Immune Control immunecontrol.com


Public list: Pharma Startups (4732) Portfolio Company Matchmaking M&A (394)

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor Pharmaceuticals Inc.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor Pharmaceuticals Inc.

Company (Merged)

Phone: 610-941-2928

Fax: 610.567.2045

200 Barr Harbor Drive
Suite 400
West Conshohocken, 19428
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immune Control $17.8M Jun 17, 2010
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immune Control Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

MacuSight

Palo Alto, California, United States
Alive / ActiveMacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of th...Show allLogin to see details

Activate Immunotherapy

San Diego, California, United States
Alive / ActiveActivate Immunotherapy (formerly NovaRx) is a clinical-stage immuno-oncology company based in San Diego, California. Activate utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells. The company's most advanced immunotherapy, Lucanix, has been tested in late stage clinical trials as a treatment for non-small cell lung cancer (NSCLC), the largest cancer indication in the world. Lucanix has promising Phase 2 and Phase 3 data. In Lucanix's Phase 2 tri...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions for treatment of diseases related to activated lymphocytes Aug 31, 2007 Jul 19, 2011 Patent
Methods for treatment of diseases related to activated lymphocytes Aug 31, 2007 Apr 12, 2011 Patent